Nuciferine Attenuates Cancer Cachexia‐Induced Muscle Wasting in Mice via HSP90AA1
ABSTRACT Background Around 80% of patients with advanced cancer have cancer cachexia (CC), a serious complication for which there are currently no FDA‐approved treatments. Nuciferine (NF) is the main active ingredient of lotus leaf, which has anti‐inflammatory, anti‐tumour and other effects. The pur...
Saved in:
| Main Authors: | Xueyan An, Lisha Ma, Yulan Bai, Chaoyue Chen, Ji Liu, Awaguli Dawuti, Kewu Zeng, Baoxue Yang, Bo Han, Abudumijiti Abulizi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13777 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nuciferine inhibits osteoclast formation through suppressing glycolysis metabolic programming and ROS production
by: Wen‐Hui Guo, et al.
Published: (2024-12-01) -
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance
by: Zhaoying Wang, et al.
Published: (2024-12-01) -
Upregulation of HSP90α in the lungs and circulation in sarcoidosis
by: Takuma Isshiki, et al.
Published: (2025-01-01) -
The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway
by: Tiantian Li, et al.
Published: (2025-05-01) -
5,7,2’,6’- Tetrahydroxyflavone affects the progression of ovarian cancer via hsa-miR-495-3p-ACTB/HSP90AA1 pathway
by: Mengjie Chen, et al.
Published: (2025-05-01)